MedTrace Logo

Trends in Modern Phase 1 Oncology Trials

NCT03676270 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6915

Last updated 2021-01-07

Study results available
· View outcomes & findings →

Summary

Overview of response rate published in recent oncology phase I trials

Conditions

Interventions

OTHER

Phase I

Chemotherapy, ITK, Hormotherapy, Immunotherapy

Sponsors & Collaborators

  • Institut Bergonié

    lead OTHER

Principal Investigators

  • Antoine Italiano, MD-PhD · Institut Bergonié

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-06-30
Completion
2018-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03676270 on ClinicalTrials.gov